PSCA: prostate stem cell antigen
US6267960A · kind A · utility
15Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 10, 1998 |
| Grant date | Jul 31, 2001 |
| Priority date | — |
| Expiry date | Mar 10, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for inhibiting the growth of prostate tumor cells expressing Prostate Stem Cell Antigen (PSCA), the methods comprising administering to a patient a monoclonal antibody which binds specifically to the extracellular domain of PSCA in an amount effective to inhibit growth of the prostate tumor cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.